Lyric Pharmaceuticals Company
Lyric is a clinical stage company developing novel gastrointestinal therapeutics for unmet medical needs in the hospital setting.
Connections from
Founded Date:
2013
Total Funding:
$20.4M
Investor Type:
For Profit
Employee Number:
1-10
Funding Status:
Early Stage Venture
Technology:
Data-driven Technologies
Last Funding Type:
Series A
Investors Number:
4
Industry:
PharmTech
Headquarters:
San Francisco, California, United States
Estimated Revenue:
$1M to $10M